PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Colistimethate sodium - Bronchiectasis
PAD Profile : Colistimethate sodium - Bronchiectasis
Keywords :
nebuliser, nebules, Home nebuliser, antibiotic, antibacterial
Brand Names Include :
Colistin, Colomycin,
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Powder
Important Information :
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialisit microbiology recommendation. Colistimethate sdoium 1million unit powder for solution for injection, infusion, inhalation vials is the most cost effective option for inhalation use by nebulisation.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
11 November 2010
Not Set
A pathway has been agreed for the use of home nebulised therapy in specific cohorts of patients. The nebuliser and ongoing consumables are supplied direct to the patients home by Philips Respironics.
Colomycin powder for injection is a more cost effective alternative to Promixin. The BNF states that Colomycin injection may be used for nebulisation
Associated BNF Codes
05. Infections
05.01.07. Some other antibacterials